288 related articles for article (PubMed ID: 31901951)
1. ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth.
Li Q; Sun Y; Liu B; Li J; Hao X; Ge W; Zhang X; Bao S; Gong J; Jiang Z; Qiu C; Zhao L; Zhao Y; Chen Y; Yang X; Ding Y; Wu Z
J Mol Med (Berl); 2020 Feb; 98(2):263-277. PubMed ID: 31901951
[TBL] [Abstract][Full Text] [Related]
2. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
3. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
4. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
[TBL] [Abstract][Full Text] [Related]
5. Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma.
Xing JS; Wang X; Lan YL; Lou JC; Ma B; Zhu T; Zhang H; Wang D; Yu Z; Yuan Z; Li XY; Zhang B
Cancer Med; 2019 Apr; 8(4):1655-1670. PubMed ID: 30740911
[TBL] [Abstract][Full Text] [Related]
6. Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1.
Wang XZ; Feng Y; Han YF; Bian Y; Liang J; Wen HM; Wu H
Toxicol Appl Pharmacol; 2020 Dec; 408():115263. PubMed ID: 33022283
[TBL] [Abstract][Full Text] [Related]
7. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
8. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
9. Trichothecin induces cell death in NF-κB constitutively activated human cancer cells via inhibition of IKKβ phosphorylation.
Su J; Zhao P; Kong L; Li X; Yan J; Zeng Y; Li Y
PLoS One; 2013; 8(8):e71333. PubMed ID: 23936501
[TBL] [Abstract][Full Text] [Related]
10. Glaucocalyxin A induces cell cycle arrest and apoptosis via inhibiting NF-κB/p65 signaling pathway in melanoma cells.
Chen J; Zhang W; Pan C; Fan J; Zhong X; Tang S
Life Sci; 2021 Apr; 271():119185. PubMed ID: 33577846
[TBL] [Abstract][Full Text] [Related]
11. miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth.
Nan Y; Guo L; Zhen Y; Wang L; Ren B; Chen X; Lu Y; Yu K; Zhong Y; Huang Q
Cell Cycle; 2021 Oct; 20(19):1967-1977. PubMed ID: 34463194
[TBL] [Abstract][Full Text] [Related]
12. AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-κB pathway in rat mesangial cells: inhibition by sesquiterpene lactones.
Wang JC; Zhao Y; Chen SJ; Long J; Jia QQ; Zhai JD; Zhang Q; Chen Y; Long HB
Cell Physiol Biochem; 2013; 32(6):1867-77. PubMed ID: 24356300
[TBL] [Abstract][Full Text] [Related]
13. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
[TBL] [Abstract][Full Text] [Related]
14. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
15. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
16. Arnicolide D exerts anti-melanoma effects and inhibits the NF-κB pathway.
Zhu P; Zheng Z; Fu X; Li J; Yin C; Chou J; Wang Y; Liu Y; Chen Y; Bai J; Wu J; Chen S; Yu ZL
Phytomedicine; 2019 Nov; 64():153065. PubMed ID: 31408803
[TBL] [Abstract][Full Text] [Related]
17. ACT001 suppressing M1 polarization against inflammation via NF-κB and STAT1 signaling pathways alleviates acute lung injury in mice.
Guo H; Song Y; Li F; Fan Y; Li Y; Zhang C; Hou H; Shi M; Zhao Z; Chen Z
Int Immunopharmacol; 2022 Sep; 110():108944. PubMed ID: 35728304
[TBL] [Abstract][Full Text] [Related]
18. t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.
Li J; Liu H; Xing B; Yu Y; Wang H; Chen G; Gu B; Zhang G; Wei D; Gu P; Li M; Hu W
J Neurooncol; 2012 Jul; 108(3):385-93. PubMed ID: 22382785
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
[TBL] [Abstract][Full Text] [Related]
20. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
